Researchers Submit Patent Application, "Engineered Imine Reductases And Methods For The Reductive Amination Of Ketone And Amine Compounds", for Approval (USPTO 20240254457).
| Předmět: | |
|---|---|
| Zdroj: | Pharma Business Week; 8/19/2024, p4121-4121, 1p |
| Abstrakt: | The article reports on a new patent application filed by Codexis Inc., detailing their innovation in engineered imine reductases designed for the efficient synthesis of chiral secondary amines. It states that this patent, filed on April 17, 2024, and published on August 1, 2024, describes biocatalysts derived from the wild-type gene of Pseudonocardia spinosispora, specifically targeting improvements in the reduction of imine substrates to secondary amines. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|